We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-12.48%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
+$13.6M
(+1.3%)
Cap. Flow
+$175M
Cap. Flow
% of AUM
16.88%
Top 10 Holdings %
Top 10 Hldgs %
6.41%
Holding
1,241
New
361
Increased
285
Reduced
228
Closed
365
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AEGN
Aegion Corp
AEGN
|
+$6.95M |
| 2 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
+$6.17M |
| 3 |
MTOR
MERITOR, Inc.
MTOR
|
+$6.08M |
| 4 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
+$5.62M |
| 5 |
KRA
Kraton Corporation
KRA
|
+$5.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NTUS
Natus Medical Inc
NTUS
|
+$5.73M |
| 2 |
Enanta Pharmaceuticals
ENTA
|
+$5.45M |
| 3 |
UNTD
UNITED ONLINE INC COM NEW
UNTD
|
+$5.41M |
| 4 |
JIVE
Jive Software, Inc.
JIVE
|
+$5.4M |
| 5 |
Merit Medical Systems
MMSI
|
+$5.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.01% |
| 2 | Industrials | 14.63% |
| 3 | Technology | 13.41% |
| 4 | Consumer Discretionary | 11.65% |
| 5 | Financials | 6.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Ciena
CIEN
$55.3B
| $1.94M | 0.19% |
93,370
+62,306
| +201% | +$1.45M |
|
177
Marcus Corp
MCS
$732M
| $1.92M | 0.19% |
99,467
+31,198
| +46% | +$611K |
|
|
AMAG
178
DELISTED
AMAG Pharmaceuticals
AMAG
| $1.92M | 0.18% |
48,211
+28,235
| +141% | +$1.75M |
|
179
Travere Therapeutics
TVTX
$5.33B
| $1.91M | 0.18% |
+94,230
| New | +$2.79M |
|
180
Andersons Inc
ANDE
$2.65B
| $1.89M | 0.18% |
+55,558
| New | +$1.99M |
|
|
OSIR
181
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $1.87M | 0.18% |
101,070
+74,983
| +287% | +$1.45M |
|
|
AT
182
DELISTED
Atlantic Power Corporation
AT
| $1.86M | 0.18% |
+1,001,305
| New | +$2.4M |
|
|
CKP
183
DELISTED
CHECKPOINT SYSTEMS INC
CKP
| $1.86M | 0.18% |
256,732
+45,641
| +22% | +$381K |
|
|
HAYN
184
DELISTED
Haynes International, Inc.
HAYN
| $1.84M | 0.18% |
+48,573
| New | +$1.99M |
|
|
RSTI
185
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $1.81M | 0.17% |
+69,973
| New | +$1.78M |
|
186
Integra LifeSciences
IART
$1.54B
| $1.81M | 0.17% |
60,696
-5,789
| -9% | -$181K |
|
|
CORI
187
DELISTED
Corium International, Inc.
CORI
| $1.8M | 0.17% |
192,390
+157,944
| +459% | +$1.89M |
|
|
BBRG
188
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
| $1.79M | 0.17% |
159,276
+66,263
| +71% | +$841K |
|
189
M/I Homes
MHO
$3.83B
| $1.76M | 0.17% |
+74,682
| New | +$1.85M |
|
|
TAX
190
DELISTED
Liberty Tax, Inc. Class A
TAX
| $1.76M | 0.17% |
75,570
+60,862
| +414% | +$1.48M |
|
191
Curis
CRIS
$9.53M
| $1.76M | 0.17% |
435
+186
| +75% | +$1.05M |
|
192
Lifecore Biomedical
LFCR
$162M
| $1.75M | 0.17% |
150,224
+79,222
| +112% | +$1.05M |
|
193
Darling Ingredients
DAR
$9.93B
| $1.75M | 0.17% |
155,514
+48,159
| +45% | +$615K |
|
194
Repligen
RGEN
$7.44B
| $1.72M | 0.17% |
+61,802
| New | +$2.23M |
|
195
Benchmark Electronics
BHE
$2.91B
| $1.72M | 0.17% |
79,029
+62,285
| +372% | +$1.33M |
|
|
SPPI
196
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.71M | 0.17% |
+286,105
| New | +$1.99M |
|
|
NEWP
197
DELISTED
NEWPORT CORP
NEWP
| $1.71M | 0.16% |
124,075
+93,157
| +301% | +$1.46M |
|
198
NWPX Infrastructure Inc
NWPX
$1.25B
| $1.7M | 0.16% |
+129,860
| New | +$2.16M |
|
199
Group 1 Automotive
GPI
$3.94B
| $1.7M | 0.16% |
+19,909
| New | +$1.79M |
|
200
Children's Place
PLCE
$53.6M
| $1.7M | 0.16% |
+29,397
| New | +$1.77M |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q3 2015 Portfolio in Review
As of Q3 2015, TFS Capital held 1,241 positions worth $1.04B, up 1.3% from $1.02B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
TFS Capital deployed $175M of net new capital in Q3 2015, opening 361 new positions and adding to 285 existing holdings. Its largest new stake was Aegion Corp: 384,454 shares worth $6.34M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 21% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Merit Medical Systems, an estimated $5.27M trimmed.
- TFS Capital's largest Q3 2015 buy was Aegion Corp: 384,454 shares worth $6.34M.
- TFS Capital added most to Pernix Therapeutics Holdings, Inc. in Q3 2015, an estimated $6.17M increase.
- TFS Capital's biggest Q3 2015 reduction was Merit Medical Systems, cutting an estimated $5.27M.
- TFS Capital fully exited Natus Medical Inc in Q3 2015, selling an estimated $5.73M.
- TFS Capital's ten largest holdings make up 6.4% of its $1.04B portfolio in Q3 2015.
- TFS Capital opened 361 new positions and closed 365 in Q3 2015.
- TFS Capital's portfolio value rose 1.3% quarter-over-quarter to $1.04B.
Based on TFS Capital's 13F filing for Q3 2015, filed 3 Nov 2015.